Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?

Mario Cazzola

doi:10.1038/ncponc0001

Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	22-23
Number of pages	2
Journal	Nature Clinical Practice Oncology
Volume	1
Issue number	1
DOIs	https://doi.org/10.1038/ncponc0001
Publication status	Published - Nov 2004

Keywords

Blood transfusion
Erythropoietin
Granulocyte-colony-stimulating factor
Neuroblastoma

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/ncponc0001

Cite this

@article{91810c17fdb341bc89350ec171684ca2,

title = "Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?",

keywords = "Blood transfusion, Erythropoietin, Granulocyte-colony-stimulating factor, Neuroblastoma",

author = "Mario Cazzola",

year = "2004",

month = nov,

doi = "10.1038/ncponc0001",

language = "English",

volume = "1",

pages = "22--23",

journal = "Nature Clinical Practice Oncology",

issn = "1743-4254",